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Core-shell nanofibers as drug delivery systems
Core-shell nanofibers have grown in popularity over the last 
decade owing to their special features and their many applica-
tions in biomedicine. They can be produced by electrospinning 
of immiscible polymer blends or emulsions through a single 
nozzle or by electrospinning using a coaxial nozzle. Several of 
the electrospinning parameters allow great versatility for the 
compositions and diameters of core-shell nanofibers to be pro-
duced. Morphology of core-shell nanofibers can be investigated 
using transmission electron microscopy and, in some cases, 
scanning electron microscopy. Several studies have shown that 
core-shell nanofibers have some advantages over monolithic 
nanofibers, such as better drug, protein, gene or probiotic incor-
poration into the nanofibers, greater control over drug release, 
and maintenance of protein structure and activity during elec-
trospinning. We herein review the production and characteriza-
tion of core-shell nanofibers, the critical parameters that affect 
their development, and their advantages as delivery systems. 
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Nanofibers and microfibers can have diameters of a few nanometers to several mi-
crometers. They are composed of natural and/or synthetic polymers, and are most fre-
quently produced using the electrospinning technique (1). Over the last few decades, elec-
trospinning has grown in popularity and is now used for the production of different 
monolithic or blended nanofibers for several applications (2). In 2003, coaxial electrospin-
ning was discovered to be a promising method for the preparation of a novel class of 
nanofibers with core-shell or core-sheath structures using a coaxial nozzle (3). Three years 
later, emulsion electrospinning using a single nozzle was shown to produce similarly 
structured nanofibers (4).
Interest in nanofibers rapidly increased in the last decade, with 56 articles published 
in 2004, while since 2014 more than 1000 articles have been published each year (Fig. 1). 
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Interest in core-shell nanofibers has also increased, and they have represented 1 to 5 % of 
all nanofiber publications over these years.
Polymeric nanofibers have several remarkable features, which include nanoscale dia-
meters, unlimited lengths (theoretically), high surface-to-volume ratios, and porous struc-
tures, both individually and as mats. These characteristics have provided them with 
 improved mechanical performance and flexibility compared to any other forms of the 
same material (2, 5, 6). Therefore, in the last 15 years, electrospun fibers have emerged as 
promising materials in many fields, including filtration (7), packaging (8), electronics (9), 
and biomedicine. In biomedicine in particular, as nanofibers have the striking feature that 
they resemble an extracellular matrix, they have grown in popularity as drug delivery 
systems and as powerful materials for tissue engineering (10, 11).
Although monolithic and blended nanofibers have promising characteristics, there 
are some disadvantages that provide considerable challenges, such as their incorporation 
of hydrophilic drugs, proteins, and cells, with their high drug loading and preserved drug 
or protein activity, and their prolonged release without burst effects (12). Therefore, seve ral 
studies have developed core-shell nanofibers to solve these problems. This review focuses 
on the methods for the production of core-shell nanofibers as a single step, parameters that 
affect these processes, characterization techniques, and presentation of core-shell nanofibers 
as a drug delivery system.
INTRODUCTION TO ELECTROSPINNING
Electrospinning is the process that produces nanofibers and microfibers from visco-
elastic polymer solutions or melts. An electrospinning set-up consists of a pump, a single, 
coaxial, or triaxial nozzle, a high-voltage source applied to the nozzle, and a grounded or 
oppositely charged collector (Fig. 2). A polymer dispersion (i.e., solution, miscible polymer 
blend, immiscible polymer blend, emulsion) is pumped through the nozzle, on the tip of 
which a drop appears, which is held by surface-tension forces (4, 13–15). When high voltage 
is applied to the nozzle, charge is induced within the polymer dispersion. When electrical 
forces overcome those of the droplet surface tension in the charged polymer solution, a 
Fig. 1. The number of publications on nanofibers and core-shell nanofibers published between 1996 
and 2017 (source: PubMed).
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Taylor cone is formed and the jet is pulled by the electric field toward the grounded collec-
tor. The jet undergoes stretching and whipping, and it solidifies due to solvent evaporation 
before it is deposited as a nanofiber mat on the grounded collector (13). The electrospin-
ning process is influenced by the dispersion used (e.g., polymer type, concentration, viscos-
ity, conductivity, surface tension), the processing factors (e.g., electric field strength, flow 
rate, collector set-up), and the ambient parameters (e.g., temperature, humidity), which 
have been previously described in detail (1, 2, 13, 16, 17).
Electrospinning using a single nozzle for the production of core-shell nanofibers
A single nozzle is commonly used for the electrospinning of nanofibers that are 
formed from one polymer (monolithic) or more polymers (blended). However, in special 
cases, electrospinning of polymer blends and emulsions can result in core-shell nanofibers 
(Fig. 3).
Electrospinning of immiscible polymer blends. – Polymer mixtures can be classified as 
miscible or immiscible polymer blends. Miscible polymer blends can form solutions with-
out any phase separation between the ingredient polymers (Fig. 3b). In contrast, immiscible 
polymer blends in the same solvent separate into two or more phases (Fig. 3c) due to their 
thermodynamic incompatibility (15, 18, 19). A few examples of immiscible polymer blends 
that have been electrospun into core-shell nanofibers include poly(methyl methacrylate) 
(PMMA)/polyacrylonitrile (PAN) in a 1:1 mass ratio dissolved in dimethylformamide 
(DMF) (15), and PMMA/polycarbonate, polystyrene/PMMA, polybutadiene/polycarbonate, 
polyaniline/polystyrene and polyaniline/polycarbonate, all of which were separately 
 dissolved in tetrahydrofuran (THF) in a 1:3 mass ratio (20). Electrospinning of poly(vinyl 
pyrrolidone) and tetraethyl orthosilicate blends in ethanol produces nanotubes in a single 
step (21).
Detailed explanation of the formation of core-shell fibers from electrospinning of 
polymer blends was provided by Bazilevsky et al. (16). Briefly, their PMMA/PAN blend in 
DMF provided 100 to 200 µm PMMA/DMF drops. During electrospinning, on the tip of 
the nozzle, a drop of the inner polymer is covered with the continuous phase of the other 
Fig. 2. Schematic representation of electrospinning through a single and a coaxial nozzle.
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Fig. 3. Schematic representation of polymer dispersions: a) as polymer solution, b) miscible polymer 
blend, c) immiscible polymer blend, and d) emulsion. These can be electrospun to form: a) mono-
lithic, b) blended, and c, d) core-shell nanofibers. Electrospinning of immiscible polymer blends and 
emulsions only under optimized conditions results in core-shell nanofibers.
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polymer (Fig. 3c). When the electrical forces are sufficiently strong, a continuous phase 
entraps and sucks the drop into a core-shell jet, which can result in core-shell fibers. Theo-
retically, after electrospinning, one drop of inner phase with a diameter of 100 µm on the 
tip of the nozzle can result in a 1-m-long core of core-shell fiber with a diameter of 1 µm. 
As there are no indications of long fiber sections without a core, which are quite common 
for core-shell nanofibers produced by coaxial electrospinning, the process appears to be 
relatively robust (15). In addition, electrospinning of immiscible polymer blends with 
smaller drops can lead to multi-core or co-continuous fibers (14, 15, 18, 20).
Although polymer blends are often electrospun, formation of core-shell nanofibers 
from them has rarely been reported. One reason might be that the nanofiber morphology 
has seldom been studied using transmission electron microscopy when core-shell nanofi-
bers are not expected. Furthermore, there is a narrow window of parameters under which 
core-shell nanofibers can be formed. The most critical parameter for the formation of core-
shell nanofibers is low molecular weight of the polymer, since during electrospinning, 
polymers with higher mobility will preferentially organize into a core-shell rather than a 
co-continuous structure. Thermodynamic properties that favor the formation of core-shell 
structure include incompatibility between the two polymers and a large difference in their 
solubility parameters. Here, also, the more viscous phase was reported to form the core (20). 
Emulsion electrospinning. – Emulsions are mixtures of two or more immiscible liquids, 
where one liquid is usually dispersed as drops in the other, which is seen as a continuous 
phase (Fig. 3d). Electrospinning of emulsions through a single nozzle (i.e., emulsion elec-
trospinning) represents one of the ways to prepare core-shell fibers with successful incor-
poration of drugs, proteins and microspheres (4, 15, 20, 22). For the two types of emulsions, 
oil-in-water (23) and water-in-oil (4, 22, 24–27), the use of water-in-oil emulsions has been 
more often reported in the literature. Water-in-oil emulsions frequently consist of an aque-
ous polymer solution with a dissolved hydrophilic drug or protein as the dispersed phase, 
with the continuous phase of a solution of hydrophobic polymer in an organic solvent, 
such as chloroform (4, 27, 28). Surfactants are usually added to increase the physical stability 
of emulsions (4, 22, 24–27). Emulsion electrospinning of oil-in-water emulsions tends to 
consist of aqueous polymer solutions, thus avoiding harmful organic solvents, referred to 
as ‘green electrospinning’ (29). In such cases, the dispersed phase is an oil (e.g., mineral or 
plant oil), which is used for incorporation of hydrophobic drugs into hydrophilic nanofi-
bers (23, 29). 
In the literature, the formation of core-shell nanofibers prepared using water-in-oil 
emulsion electrospinning has been explained as follows: during the electrospinning pro-
cess, the drops stretch into an elliptical shape in the direction of the fiber due to the inter-
facial shear forces from the outer oil phase. Drops that are too large to resist the electric 
force break up into smaller drops. Viscosity of the oil phase increases more rapidly than 
the inner aqueous drops, which directs the drops to be incorporated into the fiber interior, 
rather than to be at the surface (4, 30). If the drops merge, they form the core, and thus 
emulsion electrospinning results in core-shell nanofibers (4, 25, 27, 28, 31–33). Instead of 
core-shell morphology, separate drops embedded into the fibers (4, 34) and discontinuous 
core (24) have also been reported.
Polymer concentration in an emulsion has a critical role in the formation of nanofibers 
(35), similar to what has been reported for electrospinning of polymer solutions (17). Elec-
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trospinning of emulsions with low polymer concentrations results in beaded nanofiber 
morphology, due to low viscoelasticity, and thus sufficient polymer concentration and 
polymer weight are needed for the formation of smooth nanofibers (35). Continuous phase 
should also show electrospinnability, but if the dispersed phase is not electrospinnable, 
core-shell nanofibers can still be formed (27). A dispersed phase of the emulsion with a 
high polymer concentration results in a thicker core and overall fiber diameter after elec-
trospinning compared to lower polymer concentrations (4).
The volume ratio of the dispersed phase to the continuous phase of the emulsion in-
fluences the inner structure and diameter of the fibers that can be formed (27, 35). A high 
water content for the dispersed phase in a water-in-oil emulsion leads to less uniform 
nanofibers (35) and incomplete movement of the emulsion droplets during electrospinning 
to the core thus, this results in core material close to the nanofiber surface. In addition, 
higher water contents in a water-in-oil emulsion results in decreased nanofiber diameter 
due to higher conductivity of the emulsion (27). In contrast, for an oil-in-water emulsion, 
the addition of plant oil into an aqueous poly(vinyl alcohol) (PVA) solution increases the 
emulsion viscosity, and consequently results in thicker fibers (23). 
Coaxial electrospinning: electrospinning using a coaxial nozzle for the production  
of core-shell nanofibers 
Coaxial electrospinning is the process that is now most often used for the production 
of core-shell nanofibers. In terms of immiscible polymer blended and emulsion electros-
pinning, coaxial electrospinning differs due to the pumping of two separate solutions 
through a coaxial nozzle, instead of one solution/emulsion though a single nozzle (Fig. 2) 
(18). The core and shell solutions can be composed of the same (3) or different (18, 36) poly-
mers, and sometimes the core consists of the drug solution only without any polymer 
added (37). According to some studies, both solutions need to be spinnable, whereas other 
studies have claimed that coaxial electrospinning is important for core materials that can-
not form nanofibers by themselves such as nonpolymeric Newtonian liquids (38). In addi-
tion, coaxial electrospinning can result in the formation of nanotubes (39).
For coaxial electrospinning, the core-shell droplet appears at the tip of the coaxial 
nozzle, which at the applied voltage ejects the core-shell jet. This undergoes similar electri-
cally driven bending instabilities as for the ordinary electrospinning process. Importantly, 
use of the core-shell nozzle does not guarantee formation of a core-shell jet and later on 
core-shell nanofibers, since there are also many parameters (e.g., solutions, processing, 
environmental) involved during coaxial electrospinning. In some cases, the core jet might 
not enter the shell jet, which will result in a monolithic core and/or shell nanofibers or 
beads. In particular, two types of capillary instabilities can affect core-shell jets. First, as with 
standard electrospinning, the whole jet can break up into droplets, due to surface tension 
and insufficient viscoelastic forces. The other instability is specific to the core-shell jet, where 
the core solution during coaxial electrospinning can break up into separate droplets inside 
an intact shell due to the interfacial tension between these two solutions (38).
There are a number of additional parameters that are important in core-shell nanofi-
ber preparation, compared to electrospinning of monolithic nanofibers. These are the mis-
cibility or immiscibility of the core and shell solutions, the flow rate ratio between the two 
solutions, and the protrusion of the core nozzle outside the shell nozzle (40).
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Core-shell nanofibers can be prepared from the same polymer and the same solvent 
mixture as the core and shell (3), different polymers dissolved in the same solvents as the 
core and shell (3, 18, 41), and different polymers dissolved in different solvents, which can 
be miscible, partially miscible, or immiscible (36, 42). Solvent miscibility between the core 
and shell solutions is an important parameter to consider, as this can affect the core-shell 
nanofiber formation and their morphology. Zussman et al. (43) have reported that a well-
stabilized coaxial-electrospinning process can be achieved when both solutions are suffi-
ciently viscous, spinnable, and immiscible. Chakraboty et al. (42) indicated that complete 
immiscibility between the core and shell solutions (e.g., water and chloroform) leads to 
uneven distribution of the core solution (i.e., water) inside the fiber, which increases the 
probability of defects. Decreased interfacial tension caused by the addition of a common 
secondary solvent results in fewer defects, an even distribution of the water inside the fiber, 
and thinner and uniform core-shell nanofibers (42, 44). Using the same solvent system for 
shell and core solutions decreases the interfacial tension (18), although in such cases a less 
sharp boundary between the core and shell systems has been suggested (43). On the other 
hand, theoretically, a sharp boundary between two identical polymers in core-shell nano-
fibers can be obtained because the characteristic time of diffusion spreading of a polymer 
in core-shell nanofibers is 10-fold greater compared to the solidification process (3).
The flow rate ratio between the core and shell solutions in coaxial electrospinning is 
crucial for the formulation of core-shell nanofibers. At core-shell flow rate ratios of < 1:2, 
there is insufficient shell solution to coat the core solution, which results in droplets or 
particles on the collector. Increased core-shell flow rate ratios (1:2 to 1:3) lead to occasional 
encapsulation of the core solution in the core-shell nanofibers, accompanied by many de-
fects, such as an incomplete shell. The optimum core-shell flow rate ratios are 1:3 to 1:6, 
which enable the formation of a stable core-shell Taylor cone and result in formation of 
core-shell nanofibers. Raising the core-shell flow rate ratio from 1:7 to 1:10 does not appear 
to affect the ability of the core-shell solutions to be electrospun, but reduces the amount of 
core in the core-shell nanofibers formed (18, 42).
The position of the coaxial needle is also important for successful core-shell nanofiber 
preparation. It has been shown, both theoretically and experimentally, that the core nozzle 
needs to be outside its shell counterpart by about half the radius of the shell (40). Coaxial 
electrospinning can be also typically achieved at an applied voltage similar to that for 
single electrospinning, although poor miscibility between core and shell solutions can 
require higher voltage to be applied so as to overcome the interfacial tension between the 
core and shell (42).
CHARACTERIZATION OF POLYMER SOLUTIONS/EMULSIONS 
AND CORE-SHELL NANOFIBERS
Polymer solution and emulsion characterization
Optimum solution properties are among the most important aspects for successful 
nanofiber formation. Solution parameters that are usually measured are shear viscosity, 
conductivity, and surface tension (Table I) (1, 45, 46). Rheometers with a cone-plate measur-
ing system are used to perform the rotational and oscillatory tests to define the shear 
viscosity and elastic (G’) and plastic (G’’) moduli of solutions (17, 39, 47). Interfacial shear 
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rheology enables even better correlation between the rheological characteristics of the in-
terface and the nanofiber morphology, as this gets closer to actual electrospinning condi-
tions (46, 48). In addition, elongational rheology is a relatively new method for determina-
Table I. Methods that can be used for characterization of core-shell nanofibers
Character Method Reference
Solution/emulsion characterization Bulk viscosity 17, 39, 47, 54





Optical and fluorescence microscopy 15, 18
Nanofiber morphology and drug 
distribution
Scanning electron microscopy 18, 24, 53, 54
Field-emission scanning electron 
microscopy 56
Environmental scanning electron 
microscopy 54
Transmission electron microscopy 24, 56
Optical light or fluorescence microscopy 15, 18
Atomic force microscopy 61
Energy dispersive X-ray spectroscopy 56
Electron spectroscopy for chemical analysis 56
Solid state analysis and interactions 
between nanofiber components
X-ray diffraction 56
Differential scanning calorimetry 18, 54
Attenuated total reflectance Fourier 
transform infrared spectroscopy 18, 54
Porosity Capillary flow porosimetry 56
Mercury porosimetry 62
Scanning electron microscopy images 63
Micro-computed tomography 64
Hydrophobicity Water contact angle 24, 53, 54, 65, 66
Permeability Permeation test 56
Mechanical properties Atomic force microscopy 65, 67
Tensile testing 24, 56, 66
Release studies Pharmacopean apparatus 68
Modified release tests 69–72
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tion of viscoelasticity; it is based on uniaxial elongational flow that results in self-thinning 
threads. Elongational rheology can be used to predict solution spinnability and to differ-
entiate between the rheological properties of different polymer solutions (49). Also, special 
attention needs to be paid to the interfacial tension, which can be measured by a contact-
angle system using the pendent droplet method, since it influences the stability of the 
core-shell jet of two immiscible solutions (50). Phase separation of two immiscible poly-
mers and the size of drops in the emulsion can be determined using optical and fluores-
cence microscopy (15, 18).
Nanofiber morphology
Nanofiber morphology affects the nanofiber performance, including their drug-re-
lease kinetics (51) and the responses of cells to the scaffold (52). Physical characterization 
of nanofibers in terms of their structure and morphology is usually carried out using 
electron microscopy. Geometric properties of nanofibers, including their diameter, diam-
eter distribution, orientation, and morphology (e.g., cross-section shape, surface rough-
ness) are most frequently examined using scanning electron microscopy and its variations 
(Fig. 4a) (18, 24, 53, 54). Cross-sections are used to check the core-shell structure, particu-
larly before and after a particular treatment that can remove the core (e.g., heating, immer-
sion in water) (Fig. 5) (18, 55, 56). Transmission electron microscopy is an alternative for 
measuring the diameters of extremely small nanofibers (< 300 nm) due to the better resolu-
Fig. 5. Scanning electron microscopy images of core–shell nanofibers, where ciprofloxacin was incor-
porated into a poly(vinyl alcohol) core, with the shell formed with poly(methyl methacrylate) to pro-
long drug release: a) before and b, c) after ciprofloxacin release. The study is presented in detail in 
(18).
Fig. 4. Representative images of core-shell nanofibers obtained by: a) scanning electron microscopy 
and b) transmission electron microscopy.
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tion obtained. Indeed, transmission electron microscopy is commonly used to determine 
the internal structure of core-shell nanofibers, especially to demonstrate the core-shell 
morphology (Fig. 4b) (32, 57, 58). However, studies often provide only one image of their 
core-shell nanofibers, which might not be a true representation of all of the nanofibers in 
a nanofiber mat. With microfibers, the core-shell structure can be also seen using light or 
fluorescence optical microscopy (15). Fluorescence microscopy, energy dispersive X-ray 
spectroscopy, and electron spectroscopy for chemical analysis can be also used for deter-
mination of the distribution of a drug, dye, or metal nanoparticles incorporated into core-
shell nanofibers (56). Atomic force microscopy can be used to visualize the three-dimen-
sional structure of the nanofiber mat morphology, single nanofiber and for nanofiber 
swelling rate in an aqueous medium (1, 6), although the process of obtaining an accurate 
measurement is relatively difficult due to tip convolution (2).
Understanding of the solid states of the drug and polymer incorporated into nanofi-
bers can contribute to easier explanation of the drug-release kinetics and their mechanism. 
For the polymer, drug, and other excipients, crystallinity within the nanofibers can be 
examined using X-ray diffraction and differential scanning calorimetry, while attenuated 
total reflectance Fourier transform infrared spectroscopy can be used to determine interac-
tions between the drug and excipients (2, 32, 58). 
Porosity of nanofiber mats
Nanofiber porosity is another geometric parameter important to tissue engineering. 
Pore size measurements can be made using scanning electron microscopy images (63), 
capillary flow porometry (26), and micro-computed tomography (64, 73), and also using 
mercury porosimetry (62). Electrospun nanofiber mats are usually highly porous structures 
with >90 % porosity, total pore volume ~10 mL g–1, total pore area of 23 m2 g–1, and usually 
nonordered pores with diameters from 2 µm to 465 µm (2). Limitations of mercury poro-
simetry are the possible collapse and compression of the scaffold during measurements, so 
this is not advised for electrospun scaffolds comprising fibers with diameters < 3 µm (62, 
73). Other methods for measuring nanofiber mat porosity include calculations using the 
density of the material and the volume of the nanofiber mat (10). Alternatively, porosity can 
be calculated on the basis of scanning electron microscopy image analysis, where the data 
can be only used for comparisons between nanofiber mats developed and characterized 
within a single study. This limitation applies because measurements depend on the con-
trast and brightness of the images obtained, and the number of layers being analyzed (63). 
Quynh P. Pham et al. compared the porosity of fiber mats using three techniques: mercury 
porosimetry, liquid intrusion, and gravimetry (62). They showed no statistical differences 
between these measures. An excellent review of the advantages and limitations of different 
measurement techniques for porosity was written by Ho and Hutmacher (73).
Hydrophobicity of nanofiber mats
Hydrophobicity of nanofiber mats has a key role in the determination of their overall 
performance; in particular, hydrophobicity can affect drug release (74–76), degradation of 
the polymer matrix in aqueous media (77), and cell adhesion, proliferation, and penetra-
tion into nanofiber mats (65, 78, 79). Nanofiber mats formed from hydrophobic polymers 
are usually more hydrophobic compared to polymer films from the same polymers due to 
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the air captured in the pores between the nanofibers (76, 80). Hydrophobicity is most often 
determined using the water contact angle (53). In addition, this can detect the surface 
composition of core-shell nanofibers, especially if a hydrophilic core is incorporated into a 
hydrophobic shell. With complete core incorporation, the water contact angle does not 
change, or changes minimally, while the diffusion of the core hydrophilic components to 
the nanofiber surface reduces the water contact angle (35, 53, 66).
Permeability of nanofiber mats
Nanofiber mats are also studied as physical membranes that can be introduced during 
tendon or periodontal surgery to create a protective shield between the tendon/periodon-
tium and its surrounding tissues (56, 81). An efficient membrane should prevent fibroblast 
penetration but still allow nutrient transport through the micron-sized pores. To measure 
the permeability of nanofiber mats, a permeation test can be performed using a side-by-
side permeation chamber and bovine serum albumin as the permeation molecule (56).
Mechanical properties
Mechanical properties of a nanofiber matrix are crucial for biomedical applications 
such as scaffolds, because a mat must withstand the forces exerted by growing tissue and 
the physiological activity related to biomechanics, e.g., pulsed blood flow (2). In addition, 
the mechanical properties of nanofiber mats that resemble the extracellular matrix in vivo 
provide better material performance for tissue regeneration (65). Mechanical characteriza-
tion involves a variety of approaches, which include nano-indentation, bending tests, 
resonance frequency measurements, and microscale tension tests (2). Atomic force micros-
copy can be used for the determination of Young’s modulus of a single nanofiber (1, 6, 65).
Drug release studies
Drug release is one of the most important tests for evaluation of novel nanodelivery 
systems, especially if it predicts the in vivo performance at the application site (82). As 
nanofiber systems do not have their own monography in the European Pharmacopoeia, 
the standard dissolution method for solid dose forms using a dissolution apparatus such 
as ‘Apparatus 1’ can be used to perform release studies (83). Many drug-loaded nanofiber 
systems have been investigated under ‘sink’ conditions using smaller volumes (< 500 mL 
as the minimum suggested in the European Pharmacopeia) and various stirring or shak-
ing devices (69–72). These modified tests can be chosen to resemble more closely the in vivo 
conditions or for practical reasons such as needing lower nanofiber mass for the release 
test, or problems with the availability of Apparatus I if release studies are longer than a 
few days or weeks.
CORE-SHELL NANOFIBERS AS DRUG DELIVERY SYSTEMS
Drug release parameters have been investigated for a number of drugs incorporated 
into monolithic, blended, or core-shell nanofibers. Polymers used for biomedical applica-
tions must be biocompatible, with bioadhesive and biodegradable properties usually desir-
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able (1). Material selection is of critical importance for the production of such nanofibers, 
because it affects their morphology, biocompatibility, mechanical strength, degradation 
rate, and release profile, and also their interactions with cells, which can result in a range 
of tissue responses (83, 84). Here, some functional properties of core-shell nanofibers as 
drug delivery systems are presented.
Immediate release of poorly water-soluble drugs
In drug discovery, 70 % of new drug candidates have low aqueous solubility, which 
results in poor oral bioavailability. The need to improve drug bioavailability by enhancing 
the solubility and dissolution rate is one of the important challenges to solve in pharma-
ceutical technology (85). Nanofibers represent a promising nanodelivery system for this 
application, since their characteristics include high surface-to-volume ratio, high porosity 
of nanofiber mats, nanometer diameters, and possible drug amorphization due to the rap-
id solidification process (1), which has been already shown for blended poly(ethylene ox-
ide) (PEO)/poloxamer nanofibers loaded with carvedilol (86). In addition, coaxial electros-
pinning assists in the preparation of solid dispersions of core-shell nanofibers, with 
simultaneous incorporation of a poorly water-soluble drug and different functional ingre-
dients, which can improve the dissolution and permeation properties of the incorporated 
drug. Yu et al. (87) showed that using polyvinylpyrrolidone core-shell nanofibers, acyclovir 
as a model drug can be incorporated into the core, while sodium dodecyl sulfate (a trans-
membrane enhancer) and sucralose (a sweetener) can be incorporated into the shell. These 
core-shell nanofibers can rapidly release the acyclovir (< 1 min), with a > 6-fold increased 
permeation rate compared to acyclovir powder, as shown by in vitro dissolution and per-
meation studies. A slightly different concept was shown in a study of Li et al. (88), who 
prepared core-shell nanofibers with tamoxifen citrate or quercetin, with sodium dodecyl 
sulfate and poly(vinyl pyrrolidone) K90 as the shell and poly(e-caprolactone) (PCL) as the 
core. Shell thickness was < 100 nm and thus presented an extremely thin diffusion bound-
ary layer, which increased the dissolution rate of incorporated drugs. Nanofibers that pro-
mote rapid release, especially for poorly water-soluble drugs, have the potential to be used 
as solid dispersions and oral rapid disintegration drug delivery systems (89).
Delayed drug release
The most common examples of delayed drug release are the delivery systems that can 
ensure drug release in the upper part of the small intestine after the formulation has 
passed the stomach. Such delivery systems are also known as gastro-resistant and they 
usually contain polymers that are insoluble at low pH and that can trigger drug release at 
higher pH, due to their increased solubility under these conditions (90).
Co-axial and emulsion electrospinning have been used to prepare gastro-resistant 
nanofibers, with the aims to protect acid-sensitive drugs/proteins from the low pH and 
enzymes in the stomach (91), to provide local treatments of colon diseases (e.g., for delivery 
of 5-fluorouracil, mebeverine hydrochloride, indomethacin) (92, 93), and to image colon 
abnormalities using a contrast agent (93, 94). Jia et al. used core-shell fibers with a drug-
loaded core based on mucoadhesive PEO and a shell based on a pH-sensitive copolymer 
derived from esters of acrylic and methacrylic acid polymer (i.e., Eudragit S100). This 
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 effectively delayed the release under acidic conditions, as representative of the stomach, 
whereas when transferred to pH 7.4, there was sustained release up to 22 h. They predicted 
that after dissolution of the shell, the fibers would adhere to the walls of the intestinal tract 
and provide sustained local drug release due to the mucoadhesive nature of the PEO from 
the core (93).
Various examples of monolithic or blended nanofibers that can or cannot delay drug 
release can be found in the literature (68, 95–97), and although some gastro-resistant core-
shell nanofibers have been developed (91, 93), they are not a general solution for all drugs 
(92). Thus, delayed release does not depend only on the composition, structure, presence 
of drug on the nanofiber surface, or defects in the shell of the nanofibers, but also on the 
drug properties, including its solubility at low pH, molecular weight, and interactions with 
the polymer (18, 68, 92, 95–97).
To sum up, gastro-resistant nanofibers with higher amounts of small hydrophilic 
drugs incorporated are more challenging to develop compared to the lower loading of 
nanofibers with larger hydrophobic drugs. 
Prolonged drug release
Controlled drug delivery systems that release a drug over a prolonged period can 
improve therapeutic outcomes through reduction of drug toxicity, increased efficiency, 
and reduced dosing frequency, all of which will also promote patient compliance (98). An 
initial burst release often occurs with the use of monolithic and blended nanofibers (51, 99), 
especially if the drug crystalizes in the nanofibers or is distributed on or near the nanofiber 
surface (51, 76, 100). The development of core-shell structured nanofibers can reduce this 
burst release, with prolonged release with minimal burst release shown (18).
Polymers that are often used for prolonged drug release are generally hydrophobic, 
such as PCL, poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), zein, cellulose 
acetate and PMMA (18, 44, 99, 101). These polymers can only be dissolved in organic sol-
vents, where some hydrophilic drugs are insoluble (102). In such cases, emulsion or coaxial 
electrospinning allow incorporation of hydrophilic drugs in the core using water-in-oil 
emulsions or aqueous core solutions and shell solutions prepared in organic solvents. For 
example, the hydrophilic drug metoclopramide hydrochloride was successfully incorpo-
rated into different core-shell fibers with PVA and the drug as the core and PCL, PLA and 
PLGA as shell polymers. More prolonged drug release was shown in the case of core-shell 
nanofibers compared to monolithic nanofibers made from the same polymer (99).
The release rate of a hydrophilic drug can be controlled by varying the physical and 
chemical properties of the core and shell solutions (18, 99). Each hydrophobic polymer used 
provides slightly different release kinetics (99). Drug release can be tailored by varying the 
flow rate ratio between the core and shell solutions. Co-axial electrospinning with the 
core-shell flow rate ratio of 1:5 resulted in core-shell nanofibers with fewer imperfections, 
which can include an incomplete shell (for e.g., see Fig. 5c), or cracks and open ends, and 
longer release (30 days) compared to a flow rate ratio of 1:3, which showed release over 1 
day (18). Similar effects of the flow rate ratios between cores and shells have also been 
confirmed by other studies (54). Drug release can be additionally controlled by blending 
hydrophilic and hydrophobic polymers in the core (18).
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In some cases, two-phase drug release can be desired, especially when an initial burst 
release can relieve symptoms as soon as possible, with prolonged drug release then pro-
viding the required effects for several more hours or days. These release kinetics are espe-
cially advisable for nonsteroidal anti-inflammatory drugs, antihistamines, and anti-psy-
chotics (103). Jiang et al. (44) reported 12 h biphasic release of ketoprofen encapsulated in 
both a fast releasing shell of polyvinylpyrrolidone and a prolonged releasing core of zein. 
For peripheral nerve tissue engineering, lycium barbarum polysaccharide was incorpo-
rated into core-shell nanofibers, where the core solution was an aqueous solution of this 
polysaccharide and the shell solution was from PLGA. Two stages of release kinetics were 
shown, with a fast burst release (in the first 7 days) and sustained and constant release for 
the following 53 days (66).
Core-shell nanofibers also enable incorporation of two or more drugs, as seen for ex-
ample for core-shell nanofibers composed of a core of ibuprofen, hyaluronic acid, and PEO, 
and a shell of polyethylene glycol, PCL and Ag nanoparticles. All active ingredients (i.e., 
ibuprofen, hyaluronic acid, Ag nanoparticles) were slowly released over 20 days. The de-
velopment of this multi-functional anti-adhesion nanofiber mat can reduce fibroblast at-
tachment and penetration while simultaneously preventing post-surgical infection and 
inflammation (56).
CORE-SHELL NANOFIBERS FOR INCORPORATION AND RELEASE 
OF BIOPHARMACEUTICALS
Biopharmaceuticals are defined as protein- or nucleic-acid-based pharmaceutical sub-
stances that are used for therapeutic or in vivo diagnostic purposes and are produced by 
means other than direct extraction from a native (non-engineered) biological source (104). 
The biopharmaceutical market is rapidly increasing, and it is now the fastest growing seg-
ment of pharmaceuticals, due to their specific therapeutic effects (105). However, formula-
tions of proteins still remain a major challenge, since they are prone to chemical and physi-
cal degradation, such as oxidation, deamidation, hydrolysis, conformational changes, 
undesirable adsorption to surfaces, precipitation, and aggregation (106). The problem of 
protein instability in aqueous solutions can be solved by freezing or drying because pro-
teins in the solid state are more stable than the same substances in solution (107–109). 
Electrospinning is a promising method, which in one step enables drying of proteins and 
formulation of a dosage form. Several advantages of core-shell nanofibers over monolithic 
or blended nanofibers have been shown in terms of protein delivery (110). Coaxial electro-
spinning of core-shell nanofibers can reduce to a minimum the direct contact of bioactive 
agents in an aqueous core solution with the potentially dangerous solvents of a shell, leav-
ing only the core-shell interface (38). Jiang et al. implied that the coaxial-electrospinning 
process had no detectable negative impact on either the structure or stability of lysozyme 
(111), whereas Ji et al. reported reduced activity of alkaline phosphatase after coaxial-elec-
trospinning (110, 112). With emulsion electrospinning, small morphological changes in 
lysozyme were observed, which indicated some aggregation with composite fibers with 
higher protein loading, which was probably due to inefficient encapsulation of the protein 
within the fibers. In addition, the emulsification procedure resulted in a 16 % reduction in 
protein activity, while electrospinning did not show any further increased loss of activity 
(32). Similarly, Frizzell et al. reported reduced protein activity after emulsion electrospin-
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ning, whereas electrospinning at a higher flow rate and inclusion of PVA increased the 
recovered bioactivity from 90 to 100 % for horseradish peroxidase, and from 60 to 75 % for 
alkaline phosphatase (91). It appears that protein stability during the emulsion or coaxial 
electrospinning processes depends on many different factors, which include the protein 
properties, the composition of the emulsion or core and shell solutions, and the processing 
parameters. In addition, it is difficult to compare various studies due to different analytical 
methods used, with some methods being more sensitive for the detection of protein degra da-
tion than others. 
Controlled protein release is needed for several biomedical applications, such as the 
delivery of growth factors. Core-shell nanofibers enabled sustained release of growth fac-
tors over 30 days and decreased the burst effect of the released growth factors compared to 
blended nanofibers (58). Encapsulated platelet-derived growth factor-bb and lysozyme were 
released from core-shell nanofibers over 20 days, and they maintained high bioactivities 
over this period (32, 36). Platelet-rich plasma is a natural source of growth factors, and it has 
been successfully incorporated into blended chitosan/PEO nanofibers, with release over 1 
day (113). More recently, platelet-rich plasma was also incorporated into core-shell nanofi-
bers together with PVA in the core, with the shell composed of silk fibroin and PCL (11).
In some cases, a hydrophobic polymer can form an intact shell, and the active compo-
nent cannot be released. To overcome this obstacle, porogens (i.e., materials that rapidly 
dissolve in water to open pores, such as (poly)ethylene glycol) have been added to the shell 
(36) or biodegradable shells have been used (32). Drug release can then be regulated by the 
amount and type of porogen used (36).
Protein can be released through different shell imperfections (e.g., cracks, pores, in-
complete shell) (38), which more frequently occur when there is a higher volume ratio of 
aqueous to organic phase in the case of water-in-oil emulsion electospinning (27), and a 
higher ratio of core to shell solution flow rate in the case of coaxial electrospinning (18). If 
an incomplete core-shell structure is observed and some unencapsulated protein located 
close to or loosely associated with the fiber surface, the protein is likely to be released im-
mediately (27).
Core-shell nanofibers have also been shown to be a promising option for gene deliv-
ery, especially for tissue engineering (31, 114). Plasmid DNA (pDNA) together with 
poly(ethylene glycol) was incorporated into the core of core-shell nanofibers using coaxial 
electrospinning. The shell consisted of the non-viral gene delivery vector poly(ethylenimine)-
hyaluronic acid and PCL. Complexes of pDNA with poly(ethylenimine)-hyaluronic acid 
were released over 60 days from core-shell nanofibers and successfully transfected cells 
and induced the expression of enhanced green fluorescent protein (114). Yang et al. success-
fully incorporated either pDNA or pDNA and poly(ethylene imine) polyplexes into the 
core of core-shell nanofibers using emulsion electrospinning. Poly(DL-lactide)-
poly(ethylene glycol) formed the shell, with poly(ethylene glycol) as the porogen to en-
hance the release of pDNA polyplexes, which were released over 25 days (31).
CORE-SHELL NANOFIBERS FOR INCORPORATION OF PROBIOTICS
Probiotics are live microorganisms that are beneficial for the health of the host and 
represent a new way of combating various infectious diseases (115). Electrospinning has 
been shown to be a promising single-step process to dry such bacteria and incorporate 
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them into a delivery system (116, 117). Lopez-Rubio et al. successfully incorporated B. ani-
malis Bb12 into PVA microfibers using coaxial electrospinning, without any changes in 
viability before or after the electrospinning process (118). The advantage of coaxial electro-
spinning here is that the effects of the electric charges in the core (where the bacteria are) 
were lowered due to the rapid escape of the charge to the outer surface of the shell at the 
very beginning of the core-shell jet formation (38).
CONCLUSIONS
The greatest advantage of emulsion and coaxial electrospinning is their versatility in 
terms of the types and sizes of the core-shell nanofibers that can be developed. They have 
several advantages over monolithic nanofibers, e.g., they can provide incorporation of wa-
ter-soluble drugs or organic-solvent-sensitive proteins into nanofibers from hydrophobic 
polymers, improved drug stability, more complete drug encapsulation and greater control 
of the release kinetics due to a number of variable parameters. Changes in the shell and 
core material properties relate to variations in molecular weight, polymer type and poro-
gen substances used, which can fine-tune the drug-release profiles and drug stability. 
However, fabrication of core-shell nanofibers includes several known and unknown pa-
rameters, which can be challenging in nanofiber preparation and result in low reproduci-
bility. On several occasions, different laboratories were not able to produce similar core- 
-shell nanofibers. Also, analytical techniques for nanofiber characterization are often time 
consuming and are not straightforward. In addition, in some cases, drug release from 
monolithic and core-shell nanofibers is very similar, and thus there is no special advantage 
of using the more complex processes.
Additional studies are needed in the future to better understand the effects of multiple 
parameters on the electrospinning process, nanofiber morphology, drug distribution in 
core-shell nanofibers, drug release, and in vivo effects. Use of monolithic and blended 
nanofibers in nanomedicine will be the first to arrive on the market, due to their easier 
production, higher reproducibility and already developed scale-up processes. Later, core-
shell nanofibers will emerge for biomedical cases, where monolithic or blended nanofibers 
cannot offer such functionality with regard to drug/protein/probiotic incorporation, sta-
bility and the desired release kinetics.
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